Sarma Aruna V., Townsend Mary K., Grodstein Francine, Breyer Benjamin N., Brown Jeanette S.
Dr. Aruna V. Sarma is Associate Professor, Department of Urology, University of Michigan Health System, Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI
Dr. Mary K. Townsend is Instructor, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
Diabetes impacts the function and structure of the lower urinary tract, including the bladder and prostate, which can lead to complications such as urinary incontinence, poor bladder emptying, sexual dysfunction, lower urinary tract symptoms (LUTS), and urinary tract infection. Although urologic complications increase with age in the general population, urologic complications are even more common in individuals with diabetes compared to those with normal glucose. It has been estimated that risk of urologic complications is increased 25% to 200% in men and about 50% to 200% in women among those with diabetes compared to those with normal glucose. In men with diabetes, common urologic complications include LUTS and benign prostatic hyperplasia (BPH), a histological diagnosis associated with growth of the prostate gland. LUTS, the most common clinical manifestation of BPH, occur more frequently among men with diabetes compared to men with normal glucose. Similarly, men with diabetes more commonly have BPH. The interplay of LUTS, BPH, and diabetes remains unclear. Erectile dysfunction (ED) is also common in men with diabetes, with a prevalence estimated at 23%–90%. Although less studied, type 1 diabetes appears to increase the risk of ED in a similar fashion as type 2 diabetes. In women, sound epidemiologic evidence from several studies has linked type 1 and type 2 diabetes and urinary incontinence. Prevalence of incontinence has been estimated to be about 50%–200% more common in women with type 2 diabetes than in women with normal glucose. Data on the incidence of incontinence reflect a similar pattern. There is also evidence that women with prediabetes are at higher risk for incontinence. Less research has been conducted on women with type 1 diabetes; however, incontinence also appears to be more prevalent among women with type 1 diabetes compared with women without diabetes. Health care providers should be alert for urologic complications among their patients with diabetes because these conditions are common and often go unrecognized and, thus, undertreated. Future research is needed to identify mechanisms and effective treatment and prevention strategies to decrease the psychosocial, medical, and economic costs of these chronic disorders in many men and women with diabetes.
糖尿病会影响下尿路的功能和结构,包括膀胱和前列腺,这可能导致诸如尿失禁、膀胱排空不良、性功能障碍、下尿路症状(LUTS)以及尿路感染等并发症。虽然在普通人群中,泌尿系统并发症会随着年龄增长而增加,但与血糖正常的人相比,糖尿病患者的泌尿系统并发症更为常见。据估计,与血糖正常者相比,糖尿病男性发生泌尿系统并发症的风险增加25%至200%,糖尿病女性则增加约50%至200%。在患有糖尿病的男性中,常见的泌尿系统并发症包括LUTS和良性前列腺增生(BPH),后者是一种与前列腺生长相关的组织学诊断。LUTS是BPH最常见的临床表现,与血糖正常的男性相比,在糖尿病男性中更为频繁地出现。同样,患有糖尿病的男性更常出现BPH。LUTS、BPH和糖尿病之间的相互作用仍不清楚。勃起功能障碍(ED)在糖尿病男性中也很常见,患病率估计为23% - 90%。虽然研究较少,但1型糖尿病似乎与2型糖尿病一样,会增加ED的风险。在女性中,多项研究的可靠流行病学证据将1型和2型糖尿病与尿失禁联系起来。据估计